Research Articles | Page 10 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

  1. Home
  2. Research

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Long-term efficacy and safety of romiplostim in refractory aplastic anemia: follow-up of a phase 2/3 study Dec 2023 Blood Advances Aplastic Anemia
Experience of life quality from patients with aplastic anemia: a descriptive qualitative study Dec 2023 Orphanet Journal of Rare Diseases Aplastic Anemia
Efficacy of complement inhibitors for patients with paroxysmal nocturnal hemoglobinuria: a systematic review and meta-analysis Dec 2023 Therapeutic Advances in Hematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
Plain language summary of RACE study results: addition of eltrombopag to standard treatment of severe aplastic anemia Dec 2023 Immunotherapy Aplastic Anemia
Granulocyte transfusions in severe aplastic anemia Dec 2023 Haematologica Aplastic Anemia
Paroxysmal Nocturnal Hemoglobinuria: Current Management, Unmet Needs, and Recommendations Dec 2023 Journal of Blood Medicine Paroxysmal Nocturnal Hemoglobinuria (PNH)
Conditional survival and standardized mortality ratios of patients with severe aplastic anemia surviving at least one year after hematopoietic cell transplantation or immunosuppressive therapy Dec 2023 Haematologica Aplastic Anemia
Myelodysplastic syndromes with ring sideroblasts Oct 2023 Hematological Oncology Myelodysplastic Syndromes (MDS)
Multicenter evaluation of the addition of eltrombopag to immunosuppressive therapy for adults with severe aplastic anemia Oct 2023 International Journal of Hematology Aplastic Anemia
Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT Oct 2023 Lancet Hematology Myelodysplastic Syndromes (MDS)